0.1850CAD0.00%Mkt Cap: 37.16M $P/E: —2d ago
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap37.16M $
Enterprise Value40.50M $
Revenue (TTM)624.78K $
Gross Profit369.32K $
Net Income (TTM)-3.00M $
Revenue/Share0.0022 USD
Last Price0.1850 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.00
PEG—
EV/EBITDA-15.65
EV/Revenue64.81
P/S65.48
P/B27.14
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.150013% of range0.4100
52W High0.4100 CAD
52W Low0.1500 CAD
Profitability
Gross Margin62.11%
Oper. Margin-776.89%
EBITDA Margin0.00%
Profit Margin-504.71%
ROE-231.79%
ROA-117.92%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.39M $
CapEx (TTM)35.64K $
FCF Margin-225.13%
FCF Yield-3.79%
Net Debt-416.83K $
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity0.26
Current Ratio1.37
Quick Ratio1.01
Book Value/Sh0.0070 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.7000 CAD
Upside (mean)+278.4%
Target Range0.7000 CAD – 0.7000 CAD
# Analysts1
Ownership
Shares Out.275.82M
Float276.45M
Insiders8.40%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Out.0.02%
Shares Short128.28K
Short (prev mo.)20.30K
Technical
SMA 500.2452 (-24.6%)
SMA 2000.2460 (-24.8%)
Beta0.59
S&P 52W Chg18.16%
Avg Vol (30d)234.10K
Avg Vol (10d)649.19K
Technical Indicators
RSI (14)28.5
MACD-0.0183
MACD Signal-0.0082
MACD Hist.-0.0101
BB Upper0.3175 CAD
BB Middle0.2440 CAD
BB Lower0.1705 CAD
BB Width60.27%
ATR (14)0.0148 CAD
Vol Ratio (20d)1.15x